Home/Pipeline/Hemp/Cannabis Standardization

Hemp/Cannabis Standardization

Agribiopharmaceuticals Testing/Classification

ResearchActive

Key Facts

Indication
Agribiopharmaceuticals Testing/Classification
Phase
Research
Status
Active
Company

About Vyripharm Biopharmaceuticals

Vyripharm Biopharmaceuticals is a private, pre-revenue biotech company founded in 2015, operating from the Texas Medical Center in Houston. The company is developing a novel, integrated theranostic platform (BioSync™) that combines diagnostics and therapeutics, with applications in oncology, viral infections like COVID-19, and neurological disorders. Its strategy involves building global partnerships and leveraging AI, but it faces significant risks as an early-stage company with a broad, complex pipeline and unproven technology. Key leadership includes individuals with backgrounds in academia, business development, and medicine.

View full company profile